Literature DB >> 11765380

Pathways of apoptosis and the modulation of cell death in cancer.

D E Fisher1.   

Abstract

Although cell death once was viewed exclusively as the disordered, chaotic outcome of metabolic catastrophe, apoptosis now is recognized as a highly ordered, evolutionarily conserved, and genetically selected program that is essential for normal development. The death receptor pathway of apoptosis, cytotoxic T cells, prolife survival signals, Bcl-2 family of regulators, p53 and regulated cell death in cancer, and oncogenes are reviewed. Future prospects in this arena also are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11765380     DOI: 10.1016/s0889-8588(05)70258-6

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  6 in total

1.  In vitro reconstitution of the interactions in the PIDDosome.

Authors:  Tae-ho Jang; Chao Zheng; Hao Wu; Ju-Hong Jeon; Hyun Ho Park
Journal:  Apoptosis       Date:  2010-12       Impact factor: 4.677

2.  Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line.

Authors:  Bin Wu; Qiang Zhang; Weiming Shen; Jun Zhu
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

3.  Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.

Authors:  Eyk A Schellenberger; Alexei Bogdanov; Alexander Petrovsky; Vasilis Ntziachristos; Ralph Weissleder; Lee Josephson
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

4.  Molecular pathways associated with aggressiveness of papillary thyroid cancer.

Authors:  Salvatore Benvenga; Christian A Koch
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

5.  PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly.

Authors:  Tae-ho Jang; Hyun Ho Park
Journal:  BMB Rep       Date:  2013-09       Impact factor: 4.778

6.  RAIDD mutations underlie the pathogenesis of thin lissencephaly (TLIS).

Authors:  Hyun Ji Ha; Hyun Ho Park
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.